Regions
MAIN/REGIONS
regions/
Regions
  1. Americas
  2. Asia & Oceania
  3. Europe
  4. Middle East & Africa
  1. Who We Help
  2. Insights
  3. Events
  4. Contact Us
MAIN/search
MAIN/Who We Help
Who We Help/
WHO WE HELP
  • Pharmaceutical Manufacturers
  • Emerging Biopharma
  • MedTech
  • Financial Institutions
  • Government and Public Health
  • Health Plans
  • Hospital and Health Systems
  • Insurers and Risk
  • Medical Specialty and Patient Advocacy
Pharmaceutical Manufacturers

Harness unparalleled healthcare data, advanced analytics, and cutting-edge technologies with our expertise to accelerate the development and commercialization of innovative medicines, enhancing patient lives.

Discover More
Pharmaceutical Manufacturers
Emerging Biopharma (Global page)

Boost your innovation with IQVIA's expert team. Our comprehensive solutions integrate top-tier insights, technology, and expertise to maximize your asset's success in a competitive landscape.

Discover Innovations
MedTech

Navigating MedTech's unique landscape: U.S. decision-making now rests with GPOs, IDNs, and payers, who demand solid value proof through rigorous outcomes analyses and pricing scrutiny.

Explore MedTech
MedTech
Financial Institutions

Invest in healthcare with confidence. Stay ahead of pharma and medical device trends using real-time, high-quality data. Access market insights, historical sales, prescription trends, and emerging product information for informed, risk-reduced decisions.

Access Insights
Government and Public Health

Unlock deeper health insights with unmatched data and innovative technology to enhance decision-making for your essential government programs.

Unlock Innovations
Government and Public Health
Health Plans

Accelerate digital innovation with our data-driven expertise in data science and healthcare, optimizing business processes for smarter decisions.

Navigate Health Plans
Hospital and Health Systems

Leverage digital innovation to cut costs, boost efficiency, and elevate patient engagement, all while enhancing quality and health outcomes.

Streamline Decisions
Hospital and Health Systems
Insurers and Risk

Enhance your ability to evaluate and forecast population risk swiftly and accurately by integrating unmatched data, expertise, and technology.

Uncover More
Medical Specialty and Patient Advocacy

Transform into a data-driven organization that enhances your specialty and showcases value to your members through digital transformation.

Explore Now
MAIN/Insights
Insights/
U.S. PROGRESS POINT

A curation of IQVIA's best thinking on topics and trends driving change, disruption, and progress in the United States healthcare market.

LEARN MORE
BLOGS, WHITE PAPERS & CASE STUDIES

Explore our library of insights, thought leadership, and the latest topics & trends in healthcare.

DISCOVER INSIGHTS

PODCASTS

"Discover the future through our enlightening podcasts available in the United States.

EXPLORE PODCASTS

FACT SHEET

"IQVIA AI Medical Record Review

LEARN MORE

BLOG

"Decoding DSCSA: Ensuring Compliance in the Pharmaceutical Supply Chain

READ MORE
MAIN/Events
Events/
ON-DEMAND WEBINARS

Visit our library of on-demand webinars.

WATCH ON-DEMAND WEBINARS
UPCOMING EVENTS & WEBINARS

View our upcoming events and webinars.

DISCOVER EVENTS & WEBINARS

EVENT

"26th Controlled Substances and State Regulatory Conference

REGISTER NOW
MAIN/Contact Us
Contact Us/
Blog
A Foreword: Accelerating Interoperability with USCDI
From the U.S. Progress Point Editorial Board
Aug 03, 2023

Information, and perhaps more specifically data, is the great accelerator of progress and improvement. This is as true in medicine as it is in physics, engineering, education, and just about every other discipline; our ability to understand what is happening enhances and speeds our ability to make it better.

This may seem obvious, but the reality proves otherwise. Consider a typical patient journey; even a standard pathway is likely to be somewhat fragmented, fraught with different doctors, gaps in care due to coverage, a hodgepodge of acute and chronic interactions, and a range of other complexities. The unsurprising result is a system where incomplete health histories are commonplace and timely diagnosis and effective treatment often beyond reach. This is frustrating at best and devastating at worst; consider that the timeline to diagnosis for rare diseases is 3-15 years – an extraordinary and sometimes fatal waiting time for care and relief.

The opportunity to obtain a fuller and easily accessible picture of individual health and needs is at the same time getting closer and more complicated. There is more health data available, through EHRs, personal devices, etc. than ever before, but connecting that data is increasingly hard. Establishing a collaborative environment that satisfies patients’ appetite for a healthcare system that works for them (not in spite of them) and answering the now-federal call for interoperability is an essential step in the right direction.

For patient advocacy groups and medical specialty societies focused on rare diseases in particular, interoperability is paramount. Enhancing data exchange strengthens clinical etiology and quality of life insights allowing for more effective alignment of stakeholders and ultimately better (faster) patient care.

Read more about IQVIA’s perspective on data interoperability, the significance of the United States Core Data for Interoperability (USCDI), and the open (urgent) opportunity for patient advocacy groups and medical specialty societies to be at the leading edge of progress and improvement in healthcare information.

Progress is not an individual activity – it is the fruit of collective thinking and collaborative debate. In that spirit, Progress Point publishes both original work and critical thinking from across the IQVIA organization. The paper referenced in this article was originally published on February 19, 2023 and has been re-published for the benefit of our Progress Point viewers.

The Subscribers’ Circle
Join the U.S. Progress Point Subscribers’ Circle
First looks, exclusive content, and more.
Subscribe Here
Contact Us